Diabetes Mellitus Is Associated with Increased Mortality in Patients Receiving Curative Therapy for Hepatocellular Carcinoma Full Text
The Oncologist, 06/22/2012
Shau WY et al. – Diabetes mellitus (DM) is an independent factor for poorer prognosis in patients who received curative therapy for localized hepatocellular carcinoma (HCC).



